LILIAN ELEM: Open Payments
NPI 1629634522 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 9 payments from 4 companies in 2025. Trend: 2023 $1,105 · 2024 $1,462 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $349 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: AUSTEDO XR, REXULTI, COBENFY, INGREZZA.
Industry payments across TX — which companies pay providers there.
